Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Finasteride remains stable for two years with proper storage.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Endoscopic forehead and brow lifting safely and consistently improves aged eyebrows, but may have complications.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

The new compound may be a safer alternative to finasteride for prostate protection.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

The method effectively measures drug impact on DHT levels in prostate treatments.

The study created a new method to test drugs that affect hormone processing in skin.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Finasteride's metabolites were identified, helping understand how the drug is processed in the body.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.